List of works - David W C Beasley

1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein

scientific article published on July 2004

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

scientific article

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

scientific article

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes

scientific article published on 16 April 2013

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

scientific article published on 20 March 2018

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development

scientific article published on 17 December 2020

Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad

scientific article

Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas

scientific article

Co-circulation of West Nile virus variants, Arizona, USA, 2010

scientific article published on February 2014

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes ⬇️

scientific article published on December 5, 2011

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

scientific article published on 13 March 2017

Current use and development of vaccines for Japanese encephalitis

scientific article published on January 2008

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

scientific article published on 5 November 2009

Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus

scientific article

Development pathway for biodefense vaccines

scientific article

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

scientific article (publication date: 25 April 2005)

ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses

scientific article published on January 2016

Emergence of attenuated West Nile virus variants in Texas, 2003.

scientific article published on December 2004

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

scientific article

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate

scientific article

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

scientific article

Erratum: Publisher Correction: New international guidance on quality, safety and efficacy of DNA vaccines

scientific article published on 15 July 2020

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection

scientific article published on 4 February 2004

First vaccine approval under the FDA Animal Rule

scientific article published on 25 August 2016

GeneSV - an Approach to Help Characterize Possible Variations in Genomic and Protein Sequences

scientific article

Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002

scientific article (publication date: November 2003)

Genetic variation of St. Louis encephalitis virus

scientific article

Genome sequence and attenuating mutations in West Nile virus isolate from Mexico

scientific article published in December 2004

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

scientific article

Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys

scientific article published on 11 March 2015

Introductions of West Nile virus strains to Mexico

scientific article

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States

scientific article

Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization

scientific article published on 6 November 2007

Molecular evolution of lineage 2 West Nile virus ⬇️

scientific article published on November 7, 2012

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

scientific article published on April 2002

Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model

scientific article

Mutational analysis of the West Nile virus NS4B protein ⬇️

scientific article published on February 6, 2012

NMR assignments of the sylvatic dengue 1 virus envelope protein domain III

scientific article (publication date: December 2008)

Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders

scientific article published on 19 May 2003

New international guidance on quality, safety and efficacy of DNA vaccines

scientific article published on 18 June 2020

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

scientific article

Persistent Infection with West Nile Virus Years after Initial Infection

scientific article (publication date: 2010)

Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype

scientific article published on 31 August 2005

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

scientific article published on 7 June 2016

Propagation and Titration of West Nile Virus on Vero Cells

scientific article

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

scientific article published on September 2004

Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus.

scientific article published on July 2004

Recent advances in the molecular biology of west nile virus

scientific article

Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence

scientific article

Reduced Avian Virulence and Viremia of West Nile Virus Isolates from Mexico and Texas ⬇️

scientific article published on October 1, 2011

Resurgence of West Nile neurologic disease in the United States in 2012: What happened? What needs to be done? ⬇️

scientific article published on April 26, 2013

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III

scientific article

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects ⬇️

scientific article published on May 1, 2011

Selection of thioaptamers for diagnostics and therapeutics.

scientific article published on October 2006

Short report: serological evidence of West Nile virus activity in El Salvador

scientific article

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

scientific article

Solution structure of the envelope protein domain III of dengue-4 virus

scientific article

Status of research and development of vaccines for chikungunya

scientific article

Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.

scientific article

Structure of yellow fever virus envelope protein domain III

scientific article

Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus

scientific article

Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses

scientific article published on 8 July 2014

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections

scientific article published on March 2007

Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection

scientific article

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

scientific article

Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus ⬇️

scientific article published on February 1, 2011

West Nile encephalitis

scientific article

West Nile virus in Mexico: evidence of widespread circulation since July 2002.

scientific article

Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy

scientific article published on 26 December 2014

List of works by David W C Beasley

1H, 13C and 15N resonance assignments for domain III of the West Nile virus envelope protein

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development

Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad

Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas

Co-circulation of West Nile virus variants, Arizona, USA, 2010

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes ⬇️

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

Current use and development of vaccines for Japanese encephalitis

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus

Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus

Development pathway for biodefense vaccines

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses

Emergence of attenuated West Nile virus variants in Texas, 2003.

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

Erratum: Publisher Correction: New international guidance on quality, safety and efficacy of DNA vaccines

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection

First vaccine approval under the FDA Animal Rule

GeneSV - an Approach to Help Characterize Possible Variations in Genomic and Protein Sequences

Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002

Genetic variation of St. Louis encephalitis virus

Genome sequence and attenuating mutations in West Nile virus isolate from Mexico

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys

Introductions of West Nile virus strains to Mexico

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States

Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization

Molecular evolution of lineage 2 West Nile virus ⬇️

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model

Mutational analysis of the West Nile virus NS4B protein ⬇️

NMR assignments of the sylvatic dengue 1 virus envelope protein domain III

Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders

New international guidance on quality, safety and efficacy of DNA vaccines

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

Persistent Infection with West Nile Virus Years after Initial Infection

Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

Propagation and Titration of West Nile Virus on Vero Cells

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus.

Recent advances in the molecular biology of west nile virus

Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence

Reduced Avian Virulence and Viremia of West Nile Virus Isolates from Mexico and Texas ⬇️

Resurgence of West Nile neurologic disease in the United States in 2012: What happened? What needs to be done? ⬇️

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects ⬇️

Selection of thioaptamers for diagnostics and therapeutics.

Short report: serological evidence of West Nile virus activity in El Salvador

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

Solution structure of the envelope protein domain III of dengue-4 virus

Status of research and development of vaccines for chikungunya

Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.

Structure of yellow fever virus envelope protein domain III

Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus

Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections

Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

Vaccines and Immunotherapeutics for the Prevention and Treatment of Infections with West Nile Virus ⬇️

West Nile encephalitis

West Nile virus in Mexico: evidence of widespread circulation since July 2002.

Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy